BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Luminex Corp (NQ: LMNX)
18.41 USD  +0.30 (+1.66%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
(LMNX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 17, 2013
(Stock Blog Hub, 6/29/11)
Luminex Corporation (LMNX), a developer of biological testing technologies, has completed its previously-announced acquisition of privately-held diagnostic testing company EraGen Biosciences,...(read more)
(Stock Blog Hub, 6/22/11)
Luminex Corporation (LMNX), a developer of biological testing technologies, has forged a definitive agreement to buy Madison, Wisconsin-based privately-held diagnostic testing company EraGen...(read more)
(Benzinga, 11/5/10)
Piper Jaffray has published a research report on Luminex Corporation (NASDAQ: LMNX) after the company reported revenues and losses per share lower than expected across the board. In the report, Piper Jaffray writes "Luminex increased...(read more)
Luminex (LMNX) Company Overview

There is no analysis for LMNX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here